NameBright Revenue and Competitors
Estimated Revenue & Valuation
- NameBright's estimated annual revenue is currently $3.2M per year.
- NameBright's estimated revenue per employee is $201,000
Employee Data
- NameBright has 16 Employees.
- NameBright grew their employee count by 0% last year.
NameBright's People
Name | Title | Email/Phone |
---|
NameBright Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is NameBright?
Inclinix provides site-focused patient enrollment solutions. Staffed by experts who work with sites, patients, and their advocates to solve global enrollment challenges and promote clinical research participation, Inclinix offers personalized, consultative services to pharmaceutical and biotechnology companies, CROs, and site networks. Inclinix services are available through comprehensive enrollment programs, or as needed individually. We Bring Site and Patient Experts Together To Solve Global Enrollment Challenges
keywords:N/AN/A
Total Funding
16
Number of Employees
$3.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NameBright News
++ Includes NameBright and DropCatch registrars # Includes 1&1, PSI, Cronon, United-Domains, Arsys and world4you
++ Includes NameBright and DropCatch registrars # Includes 1&1, PSI, Cronon, United-Domains, Arsys and world4you
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | 0% | N/A |
#2 | $1.2M | 16 | -11% | $1.3M |
#3 | $0.5M | 16 | 23% | $1M |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $1.6M | 16 | 7% | N/A |